544626 — Finmagine Stock Analysis

Mixed quarter: Revenue surged 70% QoQ but EBITDA and PAT margins halved as the company deliberately invested in international subsidiaries, senior hires, and marketing – masking strong full-year operational progress. quarter Investor Presentation One-Pager? Mar 2026

Revenue (FY26)

₹168.00 Cr

+35% YoY

EBITDA Margin (FY26)

15.12%

+229bps YoY; but Q4 margin fell to 11.18%

PAT (FY26)

₹16.09 Cr

+67% YoY

Order Book (Q4 end)

₹600 Cr

63% yet to be delivered

What Went Right

Full-year revenue grew 35% YoY to ₹168 Cr, driven by a 70% QoQ revenue jump in Q4 to ₹61.08 Cr.
PAT for FY26 rose 67% to ₹16.09 Cr, with net margins expanding from 7.77% to 9.58%.
Order book stood at ₹600 Cr as of March 2026, providing ~3.6x cover over FY26 revenue.
Net worth more than doubled to ₹88.31 Cr (vs ₹42.35 Cr in FY25), aided by IPO proceeds.
Expanded into Australia (new WOS), added Dr. Milind Godbole to the board, and won four NICE APAC partner awards.

What to Watch

Q4 EBITDA margin collapsed to 11.18% (from 19.79% in Q3) and PAT margin to 6.94% (from 12.82%), both significantly below the FY26 average.
Export revenue share dropped to 13.64% in Q4 vs 23.5% for full FY26, moving away from the stated 60% target.
IP-led revenue remains negligible at 3-4% of total, despite a target of 25-30%.
Domestic concentration remains high (86.4% of Q4 revenue), exposing the company to India-specific risks.
Hardware sales accounted for 4.95% of FY26 revenue, a low-margin segment that may distract from the core IP/services focus.

Management Guidance

Target 500-600 customers from current 150+ in short span.
Export revenue target: 60% of total revenue in 2-3 years (currently ~24%).
IP revenue target: 25-30% of total revenue at 40-50% margins (currently 3-4%).
₹6.80 Cr allocated to develop proprietary platforms (Prompt Base Dialer, UAM, CompliCall).

Investor Lens

The thesis – Exato as a high-growth beneficiary of AI/CX adoption – remains supported by the ₹600 Cr order book and strong full-year profit growth. However, the Q4 margin compression (EBITDA margin halved sequentially) is a red flag that tests management's credibility. The company is clearly front-loading investments in international subsidiaries (Australia, Singapore, US), senior leadership, and marketing, but these expenses must translate into visible export revenue acceleration within the next 2-3 quarters. Key watch items: (1) order book conversion pace, (2) export share recovery towards the 60% target, and (3) any sign of IP-led revenue (currently 3-4%) gaining traction. The low FY26 EBITDA margin of 15.12% (even after strong revenue growth) suggests the business still lacks operating leverage – a risk that needs to be disproved in FY27.

From investor presentation · AI-generated analysis · Not investment advice

🔒

Premium Feature

Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance

Upgrade to Premium

Already a member? Log in

📊 MIXED Revenue jumps 75% QoQ but PAT declines 10.7% YoY due to margin squeeze.

Revenue

Revenue came in at ₹60.8 Cr, up 74.9% sequentially but only 5% year-on-year. The sharp QoQ spike suggests a seasonal or one-off boost, while YoY growth remains modest.

Profitability

Net profit fell 10.7% YoY to ₹4.3 Cr, even as revenue grew. EPS stood at ₹4.32, down from the prior year. Higher costs and lower operating margins offset the topline gain.

Margins

Operating profit margin dropped to 10.63% from 13.22% a year ago and 19.23% last quarter. This indicates cost pressures or revenue mix shift that compressed profitability.

Cash Flow

Cash flow details are not disclosed for this quarter, so the quality of earnings relative to cash generation cannot be assessed.

Balance Sheet

Total borrowings stand at ₹21 Cr against reserves of ₹79 Cr, resulting in a debt-to-equity ratio of 0.74. Total assets are ₹124 Cr, indicating a moderately leveraged balance sheet.

Key Risks

Margins have compressed sharply despite revenue growth, raising concern about cost control. PAT declined YoY, and EPS dropped. The high QoQ revenue jump may not be sustainable.

Outlook

Sustaining the QoQ revenue momentum while improving margins will be critical. The company's ROCE of 26.7% and ROE of 24.4% suggest efficient capital use, but profitability trends need to reverse.

Generated by AI · Mar 2026 results · Not investment advice

🔒

Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free Account Log In

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Documents.

Access concall transcripts, annual reports, credit ratings, and investor presentations.

Upgrade to Premium Create Free Account

📊 Sector KPIs

Industry-specific KPIs with historical trend — AI-extracted from investor presentations

🔒

Premium Feature

Industry-specific KPIs with historical trend across quarters — AI-extracted from investor presentations

Upgrade to Premium

Already a member? Log in

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.